Side Effects to Know About for Enhertu in HER2-Positive Solid Tumors
Before patients receive Enhertu for HER2-positive solid tumors, it’s important to know about the potential side effects.
Source: curetoday.com
Page 24 - Solid Tumors News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Solid Tumors. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Solid Tumors Today - Breaking & Trending Today
Johnson & Johnson receives positive CHMP opinion for
This positive CHMP opinion establishes amivantamab as a new option, and the first fully-human EGFR-MET bispecific antibody, in the first-line treatment of...
Source: globenewswire.com
Enhertu Marks First Therapy Approved Across HER2-Positive Solid Tumors
Treatment with Enhertu “is an unprecedented approval” for patients with HER2-positive solid tumors who did not have many options, an expert told CURE®.
Source: curetoday.com
SpringWorks Therapeutics Announces Abstracts Accepted for Presentation at the 2024 American ...
– Results from Phase 2b ReNeu trial of mirdametinib in NF1-PN accepted for oral presentation –
Source: eagletribune.com
Tislelizumab Receives EU Approval in 3 Indications for First- and Second-Line NSCLC
Tislelizumab has been approved in Europe across 3 indications in the first and second line for select patients with non–small cell lung cancer.
Source: onclive.com